DGAP-News: Westhouse Medical Services Plc announces appointment of new member to its Medical Advisory Panel
(firmenpresse) - DGAP-News: Westhouse Medical Services plc / Key word(s): Change of
Personnel/Corporate Action
Westhouse Medical Services Plc announces appointment of new member to
its Medical Advisory Panel
03.04.2012 / 07:00
---------------------------------------------------------------------
Westhouse Medical Services Plc announces appointment of
new member to its Medical Advisory Panel
LONDON, UK, 3rd April 2012 - Healthcare specialist Westhouse Medical
Services Plc ('Ticker Symbol 5WM') today announces the appointment of Dr.
Michael Sevenoaks as a member to its Medical Advisory Panel.
Dr Michael Sevenoaks BSc (Hons), MBBS, MRCGP, DRCOG, DFFP qualified as a
doctor from St Georges Hospital Medical School, London, holding training
posts in a variety of hospital medical and surgical specialties in London
and the Home Counties as well as spending a year as a surgical registrar in
Australia. He completed his General Practice training in Chichester and
subsequently joined ICP, one of the largest group practices in the UK,
where he now holds the position of Executive Partner.
He is a director of Epsomedical, an independent chain of day surgery units,
providing diagnostic and treatment services for the NHS and private
sectors.
In addition to his medical interests, Dr. Sevenoaks also holds a first
class honours degree in Biomedical Sciences and has published research in
the field of cell and molecular biology. He maintains an active role in
clinical trials and medical research.
Jack Kaye, founder and CEO of Westhouse Medical Services commented: 'We are
pleased to welcome Dr. Sevenoaks on to the Westhouse Medical Advisory
Panel. He brings a wealth of
experience to the company in the fields of medical research and clinical
trials, which will be invaluable to us as we continue our acquisitive
growth internationally within the healthcare sector.'
Westhouse is currently developing a number of medical devices,
including BreastCheck - a
new low-cost, non-invasive breast cancer screening product which can act as
a precursor to
mammogram scanning. BreastCheck is due for launch in summer 2012.
Westhouse recently entered into negotiations for the acquisition of a
majority stake in US-listed Sunridge International. Sunridge's subsidiary,
Ophthalmic International Inc., has developed a glaucoma procedure called
PNT, which could revolutionise the way glaucoma is treated globally.
WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4
~ends~
For press information, contact:
Jo Lee / Sian Edwards/ George Baggaley
Chameleon PR
Email: westhouse(at)chameleonpr.com
Ph: +44 (0) 207 680 5500
End of Corporate News
---------------------------------------------------------------------
03.04.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
163664 03.04.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.04.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 131277
Anzahl Zeichen: 13475
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 334 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Westhouse Medical Services Plc announces appointment of new member to its Medical Advisory Panel"
steht unter der journalistisch-redaktionellen Verantwortung von
Westhouse Medical Services plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
